http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Triapitsyn Serguei Vladimirovich,Shih Hsien-Tzung,Huang Shou-Horng,Tseng Mei-Jung 한국응용곤충학회 2021 Journal of Asia-Pacific Entomology Vol.24 No.1
Fairyfly egg parasitoids (Hymenoptera: Mymaridae) of rice leafhoppers and planthoppers (Hemiptera: Cica dellidae and Delphacidae) known from Taiwan are identified taxonomically, keyed, and illustrated. Their host associations are determined by rearings using sentinel eggs of mainly four key pest species. The previously published records of such egg parasitoids in Taiwan are critically analyzed in the unfortunate absence of almost any voucher specimens. Three species of Mymaridae are shown to be the predominant egg parasitoids of one leafhopper and three planthopper major pests of rice in Taiwan: Anagrus (Anagrus) incarnatus Haliday of the green rice leafhopper Nephotettix cincticeps (Uhler) and the delphacids Laodelphax striatella (Fallén) (small brown planthopper), Nilaparvata lugens (Stål) (brown planthopper), and Sogatella furcifera (Horváth) (whitebacked planthopper), as well as Gonatocerus aegyptiacus Soyka and Mymar taprobanicum Ward of N. cincticeps. The zig-zag leafhopper Maiestas dorsalis (Motschulsky), which is also common in paddy fields, is newly recorded as a host for A. incarnatus, G. aegyptiacus, Lymaenon litoralis (Haliday), and M. taprobanicum. Additional new records of some other Mymaridae in Taiwan, mostly from the rice field agroecosystems, are indicated. Litus assamensis Rehmat and Anis, syn. nov. from India, is synonymized with L. sutil Triapitsyn and Berezovskiy from Thailand, which is also newly recorded from Taiwan.
The Evaluation of Otilonium Bromide Treatment in Asian Patients With Irritable Bowel Syndrome
( Full Young Chang ),( Ching Liang Lu ),( Jiing Chyuan Luo ),( Tseng Shing Chen ),( Mei Jung Chen ),( Hsiu Ju Chang ) 대한소화기기능성질환·운동학회(구 대한소화관운동학회) 2011 Journal of Neurogastroenterology and Motility (JNM Vol.17 No.4
Background/Aims Antispasmodics including otilonium bromide (OB) are recommended to treat irritable bowel syndrome (IBS). However, reports about OB experience in Asia is sparse. The purpose of present study was to provide the efficacy of OB in treating Asian IBS patients. Methods Overall, 117 IBS patients meeting Rome II criteria were enrolled in an 8-week, double-blind, active-controlled and single center trial. Randomized participants received either OB 40 mg or mebeverine 100 mg 3 doses daily. The primary endpoints were to evaluate the net changes of abdominal pain/discomfort frequency score (APDFS) and safety profile, while the secondary endpoints were to assess the changes in abdominal pain/discomfort intensity, flatulence, abdominal bloating, satisfied stool frequency etc. Results Finally, 49 OB and 52 mebeverine subjects were eligible for efficacy analysis. Compared to baselines in per protocol populations, the reduced APDFSs in OB and mebeverine were 0.55 ± 1.20 (P = 0.011) and 0.37 ± 1.11 (P = 0.042), respectively, to show similarly reduced scores. The most reported side effects included dry mouth, nausea and dizziness. Besides, the improved APDFSs at 4th week visit, final alleviations in abdominal pain intensity, flatulence, abdominal bloating and satisfied stool frequency with global assessments filled by both patients and investigators were significantly achieved by both treatments, and OB was not inferior to mebeverine in treating these parameters. Conclusions In Orientals, OB is as effective as mebeverine for alleviating IBS symptoms in terms of abdominal pain, flatulence, abdominal bloating etc. However, obvious side effects are also observed. A large-scaled trial and post-marketing surveillance are recommended to confirm its efficacy and safety. (J Neurogastroenterol Motil 2011;17:402-410)